 Hao Dun
Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tacrolimus | 3 | 2017 | 134 | 0.750 |
Why?
| | Transplantation, Heterotopic | 1 | 2020 | 16 | 0.710 |
Why?
| | Aorta, Abdominal | 1 | 2020 | 39 | 0.700 |
Why?
| | Graft Rejection | 5 | 2022 | 513 | 0.670 |
Why?
| | Kidney Transplantation | 6 | 2017 | 541 | 0.670 |
Why?
| | Immunosuppressive Agents | 4 | 2017 | 646 | 0.610 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2017 | 339 | 0.600 |
Why?
| | Heart Transplantation | 2 | 2022 | 665 | 0.590 |
Why?
| | B-Lymphocytes | 2 | 2020 | 766 | 0.510 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2017 | 687 | 0.390 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 959 | 0.370 |
Why?
| | Macaca fascicularis | 8 | 2017 | 50 | 0.330 |
Why?
| | Monocytes | 2 | 2022 | 502 | 0.300 |
Why?
| | Graft Survival | 4 | 2016 | 446 | 0.250 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2013 | 37 | 0.210 |
Why?
| | Receptors, Immunologic | 4 | 2009 | 201 | 0.200 |
Why?
| | Animals | 19 | 2022 | 31698 | 0.190 |
Why?
| | Mice, Inbred BALB C | 2 | 2022 | 1143 | 0.190 |
Why?
| | Phenprocoumon | 1 | 2020 | 4 | 0.180 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 28 | 0.170 |
Why?
| | Heart Injuries | 1 | 2020 | 37 | 0.170 |
Why?
| | Drug Therapy, Combination | 3 | 2017 | 951 | 0.160 |
Why?
| | Fatty Acids | 1 | 2022 | 381 | 0.160 |
Why?
| | Positron-Emission Tomography | 1 | 2020 | 259 | 0.160 |
Why?
| | Mice | 10 | 2022 | 14863 | 0.160 |
Why?
| | Acute Lung Injury | 1 | 2022 | 298 | 0.150 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 290 | 0.150 |
Why?
| | Disease Models, Animal | 4 | 2017 | 3531 | 0.150 |
Why?
| | Antibodies, Monoclonal | 2 | 2014 | 1262 | 0.150 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2017 | 12 | 0.140 |
Why?
| | Abatacept | 1 | 2016 | 40 | 0.140 |
Why?
| | Fingolimod Hydrochloride | 1 | 2017 | 29 | 0.140 |
Why?
| | CD40 Antigens | 2 | 2014 | 82 | 0.140 |
Why?
| | Mice, Inbred C57BL | 8 | 2022 | 4692 | 0.130 |
Why?
| | Immunoconjugates | 1 | 2016 | 87 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 637 | 0.120 |
Why?
| | Myocardium | 1 | 2020 | 913 | 0.120 |
Why?
| | Immunologic Memory | 1 | 2017 | 313 | 0.120 |
Why?
| | Reperfusion Injury | 2 | 2009 | 255 | 0.110 |
Why?
| | Mycophenolic Acid | 1 | 2014 | 77 | 0.110 |
Why?
| | Chondrogenesis | 1 | 2013 | 79 | 0.100 |
Why?
| | Knee Injuries | 1 | 2013 | 89 | 0.100 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 489 | 0.090 |
Why?
| | Regeneration | 1 | 2013 | 160 | 0.090 |
Why?
| | Cartilage | 1 | 2013 | 182 | 0.090 |
Why?
| | Antilymphocyte Serum | 1 | 2010 | 60 | 0.090 |
Why?
| | Osteoarthritis | 1 | 2013 | 171 | 0.090 |
Why?
| | Knee Joint | 1 | 2013 | 323 | 0.090 |
Why?
| | Urinary Incontinence | 1 | 2010 | 56 | 0.080 |
Why?
| | Sirolimus | 1 | 2010 | 181 | 0.080 |
Why?
| | Ureteral Obstruction | 1 | 2010 | 54 | 0.080 |
Why?
| | Cartilage, Articular | 1 | 2013 | 289 | 0.080 |
Why?
| | Liver | 2 | 2009 | 1637 | 0.080 |
Why?
| | Early Growth Response Protein 1 | 1 | 2009 | 24 | 0.080 |
Why?
| | Male | 12 | 2022 | 55579 | 0.080 |
Why?
| | Skin | 1 | 2013 | 655 | 0.080 |
Why?
| | Allografts | 2 | 2022 | 122 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2009 | 299 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2009 | 383 | 0.070 |
Why?
| | Receptor for Advanced Glycation End Products | 4 | 2009 | 29 | 0.070 |
Why?
| | Inflammation Mediators | 2 | 2006 | 477 | 0.060 |
Why?
| | Liver Regeneration | 1 | 2005 | 29 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2017 | 9087 | 0.060 |
Why?
| | NF-kappa B | 2 | 2005 | 641 | 0.060 |
Why?
| | Multiple Sclerosis | 1 | 2009 | 376 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2009 | 1139 | 0.060 |
Why?
| | Hepatitis | 1 | 2004 | 45 | 0.060 |
Why?
| | Ligands | 2 | 2022 | 561 | 0.060 |
Why?
| | Flow Cytometry | 2 | 2020 | 1083 | 0.060 |
Why?
| | Reactive Oxygen Species | 1 | 2006 | 531 | 0.050 |
Why?
| | Liver Diseases | 1 | 2006 | 255 | 0.050 |
Why?
| | Survival Rate | 4 | 2010 | 1644 | 0.050 |
Why?
| | Osteopontin | 1 | 2022 | 32 | 0.050 |
Why?
| | Kidney | 2 | 2022 | 1188 | 0.050 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2022 | 90 | 0.050 |
Why?
| | Tissue Donors | 1 | 2022 | 316 | 0.040 |
Why?
| | Isotope Labeling | 1 | 2020 | 69 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2014 | 663 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2010 | 66 | 0.040 |
Why?
| | CD4 Antigens | 2 | 2010 | 123 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 274 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2022 | 923 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2020 | 267 | 0.040 |
Why?
| | Female | 2 | 2022 | 59488 | 0.040 |
Why?
| | Humans | 7 | 2022 | 114654 | 0.040 |
Why?
| | B7-2 Antigen | 1 | 2016 | 25 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2016 | 140 | 0.030 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2016 | 154 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1261 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 377 | 0.030 |
Why?
| | CD40 Ligand | 1 | 2014 | 39 | 0.030 |
Why?
| | Biotinylation | 1 | 2014 | 26 | 0.030 |
Why?
| | Antigens, CD20 | 1 | 2014 | 27 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2016 | 604 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 88 | 0.030 |
Why?
| | Collagenases | 1 | 2013 | 22 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 291 | 0.030 |
Why?
| | Cytokines | 2 | 2014 | 1840 | 0.030 |
Why?
| | Clone Cells | 1 | 2013 | 247 | 0.030 |
Why?
| | Joints | 1 | 2013 | 84 | 0.030 |
Why?
| | Creatinine | 1 | 2014 | 425 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2013 | 89 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 797 | 0.020 |
Why?
| | Isoantigens | 1 | 2010 | 17 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 258 | 0.020 |
Why?
| | Haplorhini | 1 | 2010 | 57 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2010 | 195 | 0.020 |
Why?
| | Drug Synergism | 1 | 2010 | 316 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1629 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2010 | 233 | 0.020 |
Why?
| | Random Allocation | 1 | 2010 | 335 | 0.020 |
Why?
| | P-Selectin | 1 | 2009 | 25 | 0.020 |
Why?
| | Chemokine CXCL2 | 1 | 2009 | 41 | 0.020 |
Why?
| | Self Tolerance | 1 | 2009 | 28 | 0.020 |
Why?
| | Postoperative Care | 1 | 2010 | 222 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 113 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 144 | 0.020 |
Why?
| | Apoptosis | 2 | 2009 | 2362 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2009 | 2319 | 0.020 |
Why?
| | Acute Disease | 1 | 2010 | 910 | 0.020 |
Why?
| | Reoperation | 1 | 2010 | 514 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1121 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 431 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 356 | 0.020 |
Why?
| | Glycation End Products, Advanced | 1 | 2006 | 57 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2009 | 435 | 0.020 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2006 | 125 | 0.010 |
Why?
| | Hepatectomy | 1 | 2005 | 119 | 0.010 |
Why?
| | Transcription Factor AP-1 | 1 | 2004 | 80 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 6115 | 0.010 |
Why?
| | Acetaminophen | 1 | 2006 | 241 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 3885 | 0.010 |
Why?
| | Cell Lineage | 1 | 2005 | 309 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2009 | 2568 | 0.010 |
Why?
| | Cell Death | 1 | 2004 | 322 | 0.010 |
Why?
| | Signal Transduction | 2 | 2006 | 4512 | 0.010 |
Why?
| | Homeostasis | 1 | 2004 | 573 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2004 | 666 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2005 | 1947 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2010 | 2128 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2186 | 0.010 |
Why?
| | Risk Factors | 1 | 2010 | 8631 | 0.010 |
Why?
|
|
Dun's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|